AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paper (draft)
10 February 2021
| COVID-19: Critical preparedness, readiness and response
Overview
This document provides the background evidence related to the Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca
Related document:
WHO Team
Immunization, Vaccines and Biologicals (IVB),
WHO Headquarters (HQ)
Number of pages
52
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/AZD1222/background/2021.1